Four-year survival rates for patients with metastatic melanoma who received ipilimumab in phase II clinical trials

Jedd D. Wolchok, Jeffrey S. Weber, Michele Maio et al. · Annals of Oncology · 2013

Cited by 176 works. doi:10.1093/annonc/mdt161 Open-access PDF

Authors

References